A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction
The DOI matches its Crossref record; 10 of the 11 references it cites were found in a registry or an index.
Abstract
The global endemic of cardiovascular diseases calls for improved risk assessment and treatment. Here, we describe an association between myocardial infarction (MI) and a common sequence variant on chromosome 9p21. This study included a total of 4587 cases and 12,767 controls. The identified variant, adjacent to the tumor suppressor genes CDKN2A and CDKN2B , was associated with the disease with high significance. Approximately 21% of individuals in the population are homozygous for this variant, and their estimated risk of suffering myocardial infarction is 1.64 times as great as that of noncarriers. The corresponding risk is 2.02 times as great for early-onset cases. The population attributable risk is 21% for MI in general and 31% for early-onset cases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and has also been robustly associated with CHD outcomes.(40-42)”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [41]
In the citing paper
“Additionally, endometriosis and CHD may share common genetic susceptibilities.”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [41]
In the citing paper
“Since 2007, genomewide association analyses have identified more than 50 independent loci associated with the risk of coronary artery disease.7–15”
From Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease (2016) · cites this paper as [8]
In the citing paper
“Interestingly, atherosclerotic plaques from patients carrying a genetic variation at the 9p21 locus (which includes the CDKN2B gene), which has been associated with atherosclerosis in humans204,205, have reduced levels of calreticulin compared with atherosclerotic plaques from non-carriers203, further supporting a role for defective efferocytosis in cardiovascular disease206.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [204]
In the citing paper
“Examples include the region at 8q24 associated with prostate, breast, and colon cancer, 300 kb from the nearest gene (103, 104), and the region at 9q21 associated with myocardial infarction and T2D, 150 kb from the nearest genes encoding CDKN2A and CDKN2B (99–101, 105–107).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [107]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Genomic Control for Association Studies
Devlin, B., & Roeder, K. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00997.x · Cited by 3,162
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009
Vascular Cell Senescence: Contribution to Atherosclerosis
Minamino, T., & Komuro, I. (2007) · Circulation Research · doi:10.1161/01.res.0000256837.40544.4a · Cited by 542
Heritability of death from coronary heart disease: a 36‐year follow‐up of 20 966 Swedish twins
Zdravkovic, S., Wienke, A., Pedersen, N. L., Marenberg, M. E., Yashin, A. I., & De Faire, U. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01029.x · Cited by 511
Wang, Q., Rao, S., Shen, G.-Q., Li, L., Moliterno, D. J., Newby, L. K., Rogers, W. J., Cannata, R., Zirzow, E., Elston, R. C., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381560 · Cited by 217
Samani, N. J. (2005) · The American Journal of Human Genetics · doi:10.1086/498653 · Cited by 126
Zintzaras, E., & Kitsios, G. D. (2006) · Journal of Human Genetics · doi:10.1007/s10038-006-0053-x · Cited by 24
Research works printed but not linked: 2
- T. Thom et al., Circulation113, e85 (2006).
- N. Mantel, W. Haenszel, J. Natl. Cancer Inst.22, 719 (1959).
Cited by
Items 901–1,000 of 1,001
Wang, Y., Zhang, W., Li, S., Song, W., Chen, J., & Hui, R. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.116 · Cited by 13
Genetic Profiling for Risk Reduction in Human Cardiovascular Disease
Puckelwartz, M. J., & McNally, E. M. (2014) · Genes · doi:10.3390/genes5010214 · Cited by 17
Planning a genome-wide association study: Points to consider
Hakonarson, H. H., & Grant, S. F. A. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.573803 · Cited by 17
Patel, R. S., Morris, A. A., Ahmed, Y., Kavtaradze, N., Sher, S., Su, S., Zafari, A. M., Din-Dzietham, R., Waddy, S. P., Vaccarino, V., et al. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.41 · Cited by 14
Self-citationMultifactor Dimensionality Reduction as a Filter-Based Approach for Genome Wide Association Studies
Oki, N. O., & Motsinger‐Reif, A. A. (2011) · Frontiers in Genetics · doi:10.3389/fgene.2011.00080 · Cited by 15
“…have focused on finding main effects and though many studies have had some success with this strategy (Burton et al., 2007; Hakonarson et al., 2007; Helgadottir et al., 2007; Hunter et al., 2007; Plenge et al., 2007), their results still suggest that main effects do not totally account for all the…”
BackgroundA Weighted-Holm Procedure Accounting for Allele Frequencies in Genomewide Association Studies
Dalmasso, C., Génin, E., & Trégouët, D. (2008) · Genetics · doi:10.1534/genetics.108.089839 · Cited by 14
Genetic risk factors for myocardial infarction more clearly manifest for early age of first onset
Titov, B. V., Osmak, G. J., Matveeva, N. A., Kukava, N. G., Shakhnovich, R. M., Favorov, A. V., Ruda, M. Y., & Favorova, O. O. (2017) · Molecular Biology Reports · doi:10.1007/s11033-017-4112-5 · Cited by 14
Zhao, C., Cao, H.-T., Zhang, J., Jia, Q., An, F., Chen, Z.-H., Li, L., Wang, L., Ma, W., Yang, Z., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51921-3 · Cited by 14
The Impacts of Sugar-Sweetened Beverages (SSB) on Cardiovascular Health
Pietrantoni, D., & MAYROVITZ, H. N. (2022) · Cureus · doi:10.7759/cureus.26908 · Cited by 16
“Studies have shown an association between single nucleotide polymorphisms (SNPs) on chromosome 9p21 and CVD [45,46].”
BackgroundMethodMan, H. S. J., Subramaniam, N., Downs, T., Sukumar, A. N., Saha, A. D., Nair, R., Chen, L. L., Teitelbaum, D. H., Turgeon, P. J., Ku, K. H., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.103029 · Cited by 16
“Genetic variation of the lncRNA ANRIL (CDKN2BAS1) first highlighted the potential role of lncRNAs in cardiovascular disease (73).”
BackgroundZeng, Q., Yuan, Y., Wang, S., Sun, J., Zhang, T., & Qi, M. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.11.028 · Cited by 14
“Recently, several genome-wide association studies have implicated chromosome region 9p21 as a novel locus that confers susceptibility to coronary artery disease (CAD) and MI in multiple white and Asian cohorts.1-6 Two single-nucleotide polymorphisms (SNPs), rs10757274 and rs2383206, were initially identified by McPher…”
BackgroundZabalza, M., Subirana, I., Lluís-Ganella, C., Sayols-Baixeras, S., de Groot, E., Arnold, R. J., Cenarro, A., Ramos, R., Marrugat, J., & Elosúa, R. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2014.10.023 · Cited by 20
Adaptive genetic variation and heart disease risk
Parnell, L. D., Lee, Y., & Lai, C. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283378e42 · Cited by 15
The rs1333049 polymorphism on locus 9p21.3 and extreme longevity in Spanish and Japanese cohorts
Pinós, T., Fuku, N., Cámara, Y., Arai, Y., Abe, Y., Rodríguez‐Romo, G., Garatachea, N., Santos‐Lozano, A., Miró‐Casas, E., Ruiz‐Meana, M., et al. (2013) · AGE · doi:10.1007/s11357-013-9593-0 · Cited by 14
Meschia, J. F., Bushnell, C., Boden-Albala, B. M., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Fornage, M., Goldstein, L. B., et al. (2014) · Cited by 15
Genetic Research and Women’s Heart Disease: a Primer
Kavousi, M., Bielak, L. F., & Peyser, P. A. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0618-x · Cited by 14
The 9p21.3 risk locus for coronary artery disease: A 10-year search for its mechanism
Almontashiri, N. A. M. (2017) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2017.03.001 · Cited by 18
Epigenetic modulation of vascular diseases: Assessing the evidence and exploring the opportunities
Schiattarella, G. G., Madonna, R., Linthout, S. V., Thum, T., Schulz, R., Ferdinándy, P., & Perrino, C. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.02.009 · Cited by 14
Musunuru, K., Arora, P. K., Cooke, J. P., Ferguson, J. F., Hershberger, R. E., Hickey, K. T., Lee, J., Lima, J. A. C., Loscalzo, J., Pereira, N. L., et al. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/hcg.0000000000000046 · Cited by 16
Self-citationYuan, W., Zhang, W., Zhang, W., Ruan, Z., Zhu, L., Liu, Y., Mi, Y., & Zhang, L. (2020) · Bioengineered · doi:10.1080/21655979.2020.1827892 · Cited by 15
“The SNP (single nucleotide polymorphism) allele C, when present in the heterozygous genotype (GC) elevated CHD risk by 15–20% and when present in the homozygous SNP genotype (CC) elevated CHD risk by 30–40% [14,15].”
BackgroundGoumidi, L., Gauthier, K. C., Legry, V., Mayi, T. H., Houzet, A., Cottel, D., Montaye, M., Proust, C., Kee, F., Ferrières, J., et al. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.94 · Cited by 17
Prevención cardiovascular: avances y el largo camino por recorrer
Marrugat, J., Sala, J., Elosúa, R., Ramos, R., & Baena-Díez, J. M. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70152-4 · Cited by 18
Atherosclerosis: Pathogenesis, Genetics and Experimental Models
Mota, R. I., Homeister, J. W., Willis, M. S., & Bahnson, E. M. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0005998.pub3 · Cited by 17
Introduction to Genetic Association Studies
Tsao, H., & Florez, J. C. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701054 · Cited by 15
New Information on the Genetics of Stroke
Meschia, J. F. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0155-x · Cited by 12
Gupta, R. M., Schnitzler, G. R., Fang, S., Lee-Kim, V. S., & Barry, A. E. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.318328 · Cited by 14
Analysis of ANRIL Isoforms and Key Genes in Patients with Severe Coronary Artery Disease
Rodríguez‐Esparragón, F., Torres-Mata, L. B., Cazorla-Rivero, S., Serna-Gómez, J. A., González-Martín, J. M., Cánovas-Molina, Á., Medina-Suárez, J. A., Hernández, A. N. G., Estupiñán-Quintana, L., Bartolomé-Durán, M. C., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216127 · Cited by 13
Genetic Risk Factors and Mendelian Randomization in Cardiovascular Disease
Swerdlow, D. I., Hingorani, A. D., & Humphries, S. E. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0584-x · Cited by 14
Meta-analyses of four eosinophil related gene variants in coronary heart disease
Lian, J., Huang, Y., Huang, R. S., Xu, L., Le, Y., Yang, X., Xu, W., Huang, X., Ye, M., Zhou, J., et al. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-012-0862-z · Cited by 13
Hara, M., Sakata, Y., Nakatani, D., Suna, S., Usami, M., Matsumoto, S., Ozaki, K., Nishino, M., Sato, H., Kitamura, T., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005438 · Cited by 13
Genetic Analysis in Cardiovascular Disease: A Clinical Perspective
Ho, E. C., Bhindi, R., Ashley, E. A., & Figtree, G. A. (2011) · Cardiology in Review · doi:10.1097/crd.0b013e318207ffac · Cited by 15
(2008) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195312911.003.0021 · Cited by 17
Cheng, C., Lin, Y., Lin, M., Liang, W., Chen, C., Chen, C., Wu, J., Lin, T., Liao, C., Huang, S., et al. (2020) · The Journal of Gene Medicine · doi:10.1002/jgm.3305 · Cited by 13
Loss of 9p21 Regulatory Hub Promotes Kidney Cancer Progression by Upregulating HOXB13
Baietti, M. F., Zhao, P., Crowther, J., Sewduth, R. N., Troyer, L. D., Dêbiec‐Rychter, M., & Sablina, A. A. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0705 · Cited by 14
Long Non-Coding RNAs in Venous Thromboembolism: Where Do We Stand?
Marques, I. S., Tavares, V., Neto, B. V., Mota, I. N. R., Pereira, D., & Medeiros, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512103 · Cited by 16
“These studies independently identified single-nucleotide polymorphisms (SNPs) located in a locus close to the protein-coding genes CDKN2A and CDKN2B as related to susceptibility to coronary artery disease [47,48].”
BackgroundGenetic Variant rs10757278 on Chromosome 9p21 Contributes to Myocardial Infarction Susceptibility
Chen, G., Xiu-hua, F., Wang, G., Liu, G., & Bai, X. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160511678 · Cited by 13
The Chromosome 9p21 CVD- and T2D-Associated Regions in a Norwegian Population (The HUNT2 Survey)
Helgeland, Ø., Hertel, J. K., Molven, A., Ræder, H., Platou, C. G. P., Midthjell, K., Hveem, K., Nygard, O. K., Njølstad, P. R., & Johansson, S. (2015) · International Journal of Endocrinology · doi:10.1155/2015/164652 · Cited by 13
“Several SNPs in the 9p21 interval are strongly associated with MI [1–4], vascular disease [5–7], and cancer [8], all highly correlated (r > 0.”
BackgroundElosúa, R., Lluís-Ganella, C., & Lucas, G. (2009) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(09)71502-x · Cited by 16
Dissecting the Causal Genetic Mechanisms of Coronary Heart Disease
Miller, C. L., Assimes, T. L., Montgomery, S. B., & Quertermous, T. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0406-4 · Cited by 14
de Arellano, A. R., Coca, A., de la Figuera, M., Rubio‐Terres, C., Rubio-Rodríguez, D., Gracia, A. P. D., Boldeanu, A., Puig-Gilberte, J., & Salas, E. (2013) · Applied Health Economics and Health Policy · doi:10.1007/s40258-013-0053-x · Cited by 13
Ocular Expression and Distribution of Products of the POAG-Associated Chromosome 9p21 Gene Region
Chidlow, G., Wood, J. P. M., Sharma, S., Dimasi, D. P., Burdon, K. P., Casson, R. J., & Craig, J. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075067 · Cited by 13
Wang, L., Ma, X., Xu, X., & Zhang, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-00823-3 · Cited by 13
Ramuš, S. M., & Petrovič, D. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666180206112635 · Cited by 13
Lin, X., Yan, C., Gao, Y., Du, J., Zhu, X., Yu, F., Huang, T., Dai, J., Ma, H., Jiang, Y., et al. (2016) · Cancer Science · doi:10.1111/cas.13130 · Cited by 14
Precision Medicine and Cardiovascular Health: Insights from Mendelian Randomization Analyses
Spiller, W., Jung, K. J., Lee, J., & Jee, S. H. (2020) · Korean Circulation Journal · doi:10.4070/kcj.2019.0293 · Cited by 13
Li, C., Zhang, G., Li, X., Rao, S., Gong, B., Jiang, W., Hao, D., Wu, P., Wu, C., Du, L., et al. (2007) · Gene · doi:10.1016/j.gene.2007.10.028 · Cited by 13
Wiedmann, S., Neureuther, K., Stark, K. J., Reinhard, W., Kallmünzer, B., Baessler, A., Fischer, M., Linsel‐Nitschke, P., Erdmann, J., Schunkert, H., et al. (2009) · Obesity · doi:10.1038/oby.2008.669 · Cited by 13
Nawaz, S. K., Noreen, A., Rani, A., Yousaf, M., & Arshad, M. (2015) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2014.5470 · Cited by 13
Design of Tag SNP Whole Genome Genotyping Arrays
Peiffer, D. A., & Gunderson, K. L. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-538-1_4 · Cited by 18
Genes for fibrogenesis in the determination of susceptibility to myocardial infarction
Goncharova, I. A., Makeeva, O. A., Golubenko, M. V., Markov, A., Тарасенко, Н. В., Sleptcov, A. A., & Puzyrev, V. P. (2016) · Molecular Biology · doi:10.1134/s0026893315060096 · Cited by 13
Wilcox, C. S., Noble, E. P., & Oskooilar, N. (2011) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31823581fa · Cited by 16
Cupples, L. A. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f73746 · Cited by 14
Effect of 9p21.3 (lncRNA and CDKN2A/2B) variant on lipid profile
Wei, B., Liu, Y., Li, H., Peng, Y., & Luo, Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.946289 · Cited by 14
“It has been well documented that rs1333049 C allele (1), rs4977574 G allele (24), rs10757274 G allele (2), rs10757278 G allele (3), and rs10811661 T allele (25) increased the risk of CAD by 30–40% in Whites (1–3, 25) and East Asians (24, 25).”
BackgroundInfluentialFatima, L., Goyal, A., Yakkali, S., Jain, H., Raza, F. A., Peer, T., Kanagala, S. G., Sohail, A. H., & Malik, J. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102185 · Cited by 14
Salido, E., Vieira, C. D. M., Mosquera, J. V., Zade, R., Parikh, P., Suryavanshi, S., Miller, C. L., & Sardo, V. L. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.322045 · Cited by 13
Genetic Susceptibility to Periodontitis
Richter, G. M., & Schäefer, A. S. (2025) · Journal of Periodontal Research · doi:10.1111/jre.70002 · Cited by 15
Zheng, Y., Xie, X., Ma, Y., Yang, Y., Fu, Z.-Y., Li, X., Ma, X., Chen, B., & Liu, F. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-139 · Cited by 12
Genetics and coronary artery disease: present and future.
Bampali, K., Mouzarou, A., Lamnisou, K., & Babalis, D. (2014) · PubMed · Cited by 12
Rosenson, R. S., & Köenig, W. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6642-9 · Cited by 12
Genetics, its role in preventing the pandemic of coronary artery disease
Roberts, R., & Fair, J. (2021) · Clinical Cardiology · doi:10.1002/clc.23627 · Cited by 14
“9p21 as the first genetic risk variant for CAD by two independent groups.(15,16) Features of the 9p21 risk variant confirmed our initial hypothesis that there would be many risk variants contributing to”
BackgroundLaursen, I. H., Banasik, K., Haue, A. D., Petersen, O., Holm, P. C., Westergaard, D., Bundgaard, H., Brunak, S., Frikke‐Schmidt, R., Hólm, H., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049709 · Cited by 13
Self-citationSzpakowicz, A., Kiliszek, M., Pepiński, W., Waszkiewicz, E., Franaszczyk, M., Skawrońska, M., Płoski, R., Niemcunowicz‐Janica, A., Dobrzycki, S., Opolski, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104635 · Cited by 12
Zarkasi, K. A., Abdullah, N., Murad, N. A. A., Ahmad, N., & Jamal, R. (2022) · Diagnostics · doi:10.3390/diagnostics12102561 · Cited by 16
“(2007) [37] F F F FF F F F High Hirokawa et al.”
BackgroundDong, L., Wang, H., Wang, D. W., & Ding, H. (2013) · Annals of Human Genetics · doi:10.1111/ahg.12010 · Cited by 12
“Recently, GWAS have identified several SNPs on chromosome 9p21 that were significantly associated with CAD (Helgadottir et al., 2007, Mcpherson et al., 2007).”
BackgroundBi, J., Yang, L., Liu, D., Wu, J., Tong, X., Cen, S., Zhou, D., Zhang, T., & Li, Y. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2014.12.020 · Cited by 12
Song, Z., Wu, H., Cao, H., & Qin, L. (2014) · BioMed Research International · doi:10.1155/2014/370670 · Cited by 14
“Many genomewide association studies (GWAS) have identified several novel susceptibility gene loci for CAD [3–6].”
BackgroundLeu, H., Chung, C., Lin, S., Lu, T., Yang, H., Ho, H., Ting, C.-T., Lin, T., Sheu, S., Tsai, W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097919 · Cited by 15
9p21 Polymorphisms increase the risk of peripheral artery disease in the Han Chinese population
Tian, L., Fang, H., Gao, L., Tan, Z., Zhen, Y., Tian, J., Zhang, Y., Sun, X., Qin, J., Sun, Y.-N., et al. (2013) · Journal of International Medical Research · doi:10.1177/0300060512474569 · Cited by 12
Xu, J., Jiang, L., Xu, L. J., Gao, Z., Zhao, X. Y., Zhang, Y., Song, Y., Liu, R., Sun, K., Gao, R., et al. (2018) · PubMed · doi:10.3967/bes2018.106 · Cited by 12
Genetics of macrovascular complications in type 2 diabetes
Tonyan, Z. N., Nasykhova, Y. A., Danilova, M. M., & Glotov, A. S. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i8.1200 · Cited by 13
Sun, Y. V., Jacobsen, D. M., Turner, S. T., Boerwinkle, E., & Kardia, S. L. R. (2008) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2008.04.013 · Cited by 12
DNA repair, insulin signaling and sirtuins: at the crossroads between cancer and aging
Mostoslavsky, R. (2008) · Frontiers in bioscience · doi:10.2741/3203 · Cited by 13
“Furthermore, a number of aging associated disorders in humans map to the CDKN2a locus, presumably affecting Ink4a expression (although Arf or other genes may be involved) (45-47).”
BackgroundClassification of genetic profiles of Crohn’s disease: a focus on theATG16L1gene
Grant, S. F. A., Baldassano, R. N., & Hakonarson, H. H. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.2.199 · Cited by 16
Bhanushali, A. A., Parmar, N., Contractor, A., Shah, V. T., & Das, B. R. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.09.003 · Cited by 13
Genetics and the general physician: insights, applications and future challenges
Knight, J. C. (2009) · QJM · doi:10.1093/qjmed/hcp115 · Cited by 16
Hubacek, J. A., Staněk, V., Gebauerova, M., Poledne, R., Aschermann, M., Skalická, H., Matoušková, J., Krüger, A., Pěnička, M., Hrabáková, H., et al. (2012) · Folia Biologica · doi:10.14712/fb2012058050203 · Cited by 12
“One of the first detected and probably most widely analysed DNA markers is a common haplotype on chro‑ mosome 9, which is characterized by three SNPs, rs10757274, rs2891168, or rs2383207 (Helgadottir et al., 2007; McPherson et al., 2007).”
BackgroundCommentary: Genetic association studies see light at the end of the tunnel
Frayling, T. M. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym205 · Cited by 12
Myocardial ischemia and its complications
Fishbein, G. A., Fishbein, M. C., Wang, J., & Buja, L. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822224-9.00022-0 · Cited by 20
Genetic variation in 9p21, dietary patterns, and insulin sensitivity
Mahdavi, S., Jenkins, D. J. A., & El‐Sohemy, A. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.988873 · Cited by 12
“Single nucleotide polymorphisms (SNPs) in the 9p21 region increase risk of CVD events, with a population attributable risk of 20–30% for myocardial infarction (Helgadottir et al., 2007).”
BackgroundPersonalized Cardiovascular Medicine: Status in 2012
Dandona, S., & Roberts, R. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.08.020 · Cited by 10
Bellary, K., Murthy, D. K., Balakrishna, N., & Tupurani, M. A. (2019) · Indian Heart Journal · doi:10.1016/j.ihj.2019.04.005 · Cited by 11
Heterogeneous expression of alternatively spliced lncRNA mediates vascular smooth cell plasticity
Mayner, J., Masutani, E., Demeester, E., Kumar, A., Macapugay, G., Beri, P., Sardo, V. L., & Engler, A. J. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2217122120 · Cited by 11
Semaev, S., Шахтшнейдер, Е. В., Щербакова, Л. В., Orlov, P. S., Иванощук, Д. Е., Malyutina, S. K., Гафаров, В. В., Voevoda, M. I., & Ragino, Y. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310908 · Cited by 12
“This allele raises the risk of CAD by 15–20% in the heterozygous state and by 30–40% in the homozygous state [22,23].”
BackgroundDeng, A. Y., Nattel, S., Shi, Y., L’Heureux, N., Cardin, S., Ménard, A., Roy, J., & Tardif, J. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e32830a9a5e · Cited by 11
Ertelt, K., Généreux, P., Mintz, G. S., Brener, S. J., Kirtane, A. J., McAndrew, T., Francese, D. P., Ben‐Yehuda, O., Mehran, R., & Stone, G. W. (2014) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2014.09.002 · Cited by 13
“3 locus identified by 3 independent groups in 2007 [20–22].”
BackgroundSortilina e risco de doença cardiovascular
Coutinho, M. F., Bourbon, M., Prata, M. J., & Alves, S. (2013) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2013.02.006 · Cited by 12
Vasco, V. R. L., Leopizzi, M., Puggioni, C., Rocca, C. D., & Businaro, R. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2079-2 · Cited by 14
“Neuropeptide Y (NPY), the most abundant peptide in heart and brain, is mainly involved in the neuroendocrine regulation of the stress response, a complex event modulated and influenced by various molecules [2–7].”
BackgroundPredicting functionally important SNP classes based on negative selection
Levenstien, M. A., & Klein, R. J. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-26 · Cited by 11
Genomic Research to Identify Novel Pathways in the Development of Abdominal Aortic Aneurysm
Harrison, S. C., Kalea, A. Z., Holmes, M. V., Agu, O., & Humphries, S. E. (2012) · Cardiology Research and Practice · doi:10.1155/2012/852829 · Cited by 13
POLYMORPHISMS OF THE IMMUNE RESPONSE GENES:SELECTED BIOLOGICAL, METHODICAL AND MEDICAL ASPECTS
Kubistova, Z., Mrázek, F., & Petrek, M. (2009) · Biomedical Papers · doi:10.5507/bp.2009.016 · Cited by 11
Srinivasan, B. S., Chen, J., Cheng, C., Conti, D. V., Duan, S., Fridley, B. L., Gu, X., Haines, J. L., Jorgenson, E., Kraja, A. T., et al. (2009) · Pharmacogenomics · doi:10.2217/14622416.10.2.243 · Cited by 15
Recent success in the discovery of coronary artery disease genes
Roberts, R., Chen, L., Wells, G. A., & Stewart, A. F. R. (2011) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y11-041 · Cited by 14
Huang, Y., Ye, H. D., Gao, X., Nie, S., Hong, Q., Ji, H., Sun, J., Zhou, S., Fei, B., Li, K. Q., et al. (2015) · Genetics and Molecular Research · doi:10.4238/2015.october.28.3 · Cited by 11
“…Research 14 (4): 13414-13424 (2015) As shown in Figure 2, our meta-analysis involved 18 study stages (Clarke et al., 2006; Farrall et al., 2006; Helgadottir et al., 2007; Hofman et al., 2007; Samani et al., 2007; Schunkert et al., 2008; Stirnadel et al., 2008; Elliott et al., 2009; Erdmann et…”
BackgroundAntithrombotic Drug Therapy in Cardiovascular Disease
Askari, A. T., & Lincoff, A. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-235-3 · Cited by 12
Christiansen, M. K., Nyegaard, M., Pedersen, L. N., Larsen, S. B., Würtz, M., Hjort, J., Kristensen, S. D., & Jensen, H. K. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.01.010 · Cited by 13
Genética de la cardiopatía isquémica: del conocimiento actual a las implicaciones clínicas
Elosúa, R., & Sayols-Baixeras, S. (2017) · Revista Española de Cardiología · doi:10.1016/j.recesp.2017.02.033 · Cited by 12
Li, Y., Chen, Z., & Song, H.-J. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-017-0651-y · Cited by 11
Zhang, H., Mao, J.-S., & Hu, W.-F. (2019) · Medical Science Monitor · doi:10.12659/msm.915001 · Cited by 11
Lu, Z., Zhang, Y., Maimaiti, Y., Feng, Y., Sun, J., Zhuang, J., Zeng, L., & Fu, Y. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.28126 · Cited by 11
Joshi, P. H., Rinehart, S. J., Vazquez, G., Qian, Z., Sharma, A., Anderson, H., Murrieta, L., Flockhart, N., Karmpaliotis, D., Kalynych, A. M., et al. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-3652.2013.01.02 · Cited by 11
Metadata
- Authors
- Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., Jonasdottir, A., Sigurdsson, A., Baker, A., Palsson, A., Masson, G., Gudbjartsson, D. F., Magnusson, K. P., Andersen, K., Levey, A. I., Backman, V. M., Matthiasdottir, S., Jonsdottir, T., Palsson, S., Einarsdottir, H., Gunnarsdottir, S., Gylfason, A., Vaccarino, V., Hooper, W. C., Reilly, M. P., Granger, C. B., Austin, H., Rader, D. J., Shah, S. H., Quyyumi, A. A., Gulcher, J. R., Thorgeirsson, G., Thorsteinsdottir, U., Kong, A., & Stefansson, K.
- Affiliations
- deCODE genetics, Sturlugata 8, IS-101 Reykjavik, Iceland.
- deCODE Genetics (Iceland) (IS)
- Corresponding author
- Manolescu, Andrei
- Kong, Augustine
- ORCID
- Venue
- Science
- Published
- 2007-06-08
- Volume
- 316
- Issue
- 5830
- Pages
- 1491-1493
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2036198235
- Semantic Scholar
- c6c5bbe025441bb878530bbd85db55cb110ef15a
- Cited by
- 1,594
- References
- 11
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 25 · 2023: 30 · 2022: 28 · 2021: 56 · 2020: 39 · 2019: 60 · 2018: 80 · 2017: 71 · 2016: 71 · 2015: 87 · 2014: 97 · 2013: 92 · 2012: 130
- FWCI
- 98.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- myocardial infarction, chromosome 9p21, genetic susceptibility, CDKN2A, CDKN2B, tumor suppressor, single nucleotide polymorphisms, early-onset myocardial infarction, population attributable risk, cardiovascular risk
- MeSH terms
- Aged, Chromosome Mapping, Chromosomes, Human, Pair 9, Coronary Artery Disease, Female, Genotype, Haplotypes, Heterozygote, Homozygote, Humans, Male, Middle Aged, Myocardial Infarction, Risk Factors, Genetic Variation, Linkage Disequilibrium, Case-Control Studies, Age of Onset, Genes, p16, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.